O	O	0	10	Thymocytes	Thymocyte	B-NP	NNS	B-cell_type	2	SUB	B-cell_type
O	O	11	18	control	control	B-VP	VBP	O	0	ROOT	O
O	O	19	22	the	the	B-NP	DT	O	5	NMOD	O
T1	B-Protein	23	26	CD4	CD4	I-NP	NN	B-DNA	5	NMOD	B-DNA
O	O	27	31	gene	gene	I-NP	NN	I-DNA	2	OBJ	I-DNA
O	O	32	43	differently	differently	B-ADVP	RB	O	2	VMOD	O
O	O	44	48	from	from	B-PP	IN	O	6	AMOD	O
O	O	49	55	mature	mature	B-NP	JJ	B-cell_type	10	NMOD	B-cell_type
O	O	56	57	T	T	I-NP	NN	I-cell_type	10	NMOD	I-cell_type
O	O	58	69	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	69	70	.	.	O	.	O	2	P	O

O	O	72	74	We	We	B-NP	PRP	O	2	SUB	O
O	O	75	83	analyzed	analyze	B-VP	VBD	O	0	ROOT	O
O	O	84	87	the	the	B-NP	DT	O	4	NMOD	O
O	O	88	96	activity	activity	I-NP	NN	O	13	NMOD	O
O	O	97	99	of	of	B-PP	IN	O	4	NMOD	O
O	O	100	103	the	the	B-NP	DT	O	7	NMOD	O
T14	B-Entity	104	112	enhancer	enhancer	I-NP	NN	B-DNA	5	PMOD	B-DNA
O	O	112	113	,	,	O	,	O	13	P	O
O	O	114	117	the	the	B-NP	DT	O	10	NMOD	O
T15	B-Entity	118	126	promoter	promoter	I-NP	NN	B-DNA	13	NMOD	B-DNA
O	O	127	130	and	and	O	CC	O	13	NMOD	O
O	O	131	134	the	the	B-NP	DT	O	13	NMOD	O
T16	B-Entity	135	143	silencer	silencer	I-NP	NN	B-DNA	2	OBJ	B-DNA
O	O	144	146	of	of	B-PP	IN	O	13	NMOD	O
O	O	147	150	the	the	B-NP	DT	O	18	NMOD	O
O	O	151	156	human	human	I-NP	JJ	B-DNA	18	NMOD	B-DNA
T2	B-Protein	157	160	CD4	CD4	I-NP	NN	I-DNA	18	NMOD	I-DNA
O	O	161	165	gene	gene	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	166	172	during	during	B-PP	IN	O	13	NMOD	O
O	O	173	174	T	T	B-NP	NN	O	22	NMOD	O
O	O	175	179	cell	cell	I-NP	NN	O	22	NMOD	O
O	O	180	191	development	development	I-NP	NN	O	19	PMOD	O
O	O	192	197	using	use	B-VP	VBG	O	2	VMOD	O
O	O	198	208	transgenic	transgenic	B-NP	JJ	O	25	NMOD	O
O	O	209	213	mice	mouse	I-NP	NNS	O	23	OBJ	O
O	O	213	214	.	.	O	.	O	2	P	O

O	O	215	233	Immunofluorescence	Immunofluorescence	B-NP	NN	O	2	NMOD	O
O	O	234	241	studies	study	I-NP	NNS	O	18	SUB	O
O	O	242	244	on	on	B-PP	IN	O	2	NMOD	O
O	O	245	251	thymic	thymic	B-NP	JJ	B-cell_type	5	NMOD	B-cell_type
O	O	252	263	populations	population	I-NP	NNS	I-cell_type	3	PMOD	I-cell_type
O	O	264	266	of	of	B-PP	IN	O	5	NMOD	O
O	O	267	271	mice	mouse	B-NP	NNS	O	6	PMOD	O
O	O	272	280	carrying	carry	B-VP	VBG	O	7	NMOD	O
O	O	281	291	transgenes	transgene	B-NP	NNS	O	8	OBJ	O
O	O	292	294	in	in	B-PP	IN	O	9	NMOD	O
O	O	295	302	various	various	B-NP	JJ	O	12	NMOD	O
O	O	303	315	combinations	combination	I-NP	NNS	O	10	PMOD	O
O	O	316	318	of	of	B-PP	IN	O	12	NMOD	O
O	O	319	324	these	these	B-NP	DT	O	17	NMOD	O
T17	B-Entity	325	335	regulatory	regulatory	I-NP	JJ	B-DNA	17	NMOD	B-DNA
T17	I-Entity	336	339	DNA	DNA	I-NP	NN	I-DNA	17	NMOD	I-DNA
T17	I-Entity	340	348	elements	element	I-NP	NNS	I-DNA	13	PMOD	I-DNA
O	O	349	357	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	358	362	that	that	B-SBAR	IN	O	18	VMOD	O
O	O	363	373	thymocytes	thymocyte	B-NP	NNS	B-cell_type	21	SUB	B-cell_type
O	O	374	381	control	control	B-VP	VBP	O	19	SBAR	O
O	O	382	385	the	the	B-NP	DT	O	24	NMOD	O
T3	B-Protein	386	389	CD4	CD4	I-NP	NN	B-DNA	24	NMOD	B-DNA
O	O	390	394	gene	gene	I-NP	NN	I-DNA	21	OBJ	I-DNA
O	O	395	397	in	in	B-PP	IN	O	21	VMOD	O
O	O	398	399	a	a	B-NP	DT	O	28	NMOD	O
O	O	400	409	different	different	I-NP	JJ	O	28	NMOD	O
O	O	410	416	manner	manner	I-NP	NN	O	25	PMOD	O
O	O	417	421	than	than	B-PP	IN	O	28	NMOD	O
O	O	422	428	mature	mature	B-NP	JJ	B-cell_type	33	NMOD	B-cell_type
O	O	429	439	peripheral	peripheral	I-NP	JJ	I-cell_type	33	NMOD	I-cell_type
O	O	440	441	T	T	I-NP	NN	I-cell_type	33	NMOD	I-cell_type
O	O	442	453	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	29	PMOD	I-cell_type
O	O	453	454	.	.	O	.	O	18	P	O

O	O	455	458	The	The	B-NP	DT	O	7	NMOD	O
T18	B-Entity	459	460	5	5	I-NP	CD	B-DNA	7	NMOD	B-DNA
T18	I-Entity	460	461	'	'	I-NP	SYM	I-DNA	7	NMOD	I-DNA
T18	I-Entity	461	462	-	-	I-NP	HYPH	I-DNA	7	NMOD	I-DNA
T18	I-Entity	462	470	positive	positive	I-NP	JJ	I-DNA	7	NMOD	I-DNA
T18	I-Entity	471	481	regulatory	regulatory	I-NP	JJ	I-DNA	7	NMOD	I-DNA
T18	I-Entity	482	486	unit	unit	I-NP	NN	I-DNA	19	SUB	I-DNA
O	O	486	487	,	,	O	,	O	7	P	O
O	O	488	498	consisting	consist	B-VP	VBG	O	7	NMOD	O
O	O	499	501	of	of	B-PP	IN	O	9	VMOD	O
O	O	502	505	the	the	B-NP	DT	O	12	NMOD	O
T19	B-Entity	506	514	promoter	promoter	I-NP	NN	B-DNA	17	NMOD	B-DNA
O	O	515	518	and	and	O	CC	O	17	NMOD	O
O	O	519	522	the	the	B-NP	DT	O	17	NMOD	O
T20	B-Entity	523	524	5	5	I-NP	CD	B-DNA	17	NMOD	B-DNA
T20	I-Entity	524	525	'	'	I-NP	SYM	I-DNA	17	NMOD	I-DNA
T20	I-Entity	526	534	enhancer	enhancer	I-NP	NN	I-DNA	10	PMOD	I-DNA
O	O	534	535	,	,	O	,	O	7	P	O
O	O	536	538	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	539	546	already	already	B-ADVP	RB	O	21	AMOD	O
O	O	547	553	active	active	B-ADJP	JJ	O	19	PRD	O
O	O	554	556	at	at	B-PP	IN	O	21	AMOD	O
O	O	557	560	the	the	B-NP	DT	O	34	NMOD	O
T4	B-Protein	561	564	CD4	CD4	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	564	565	-	-	B-NP	HYPH	O	26	P	O
T21	B-Entity	565	568	CD8	CD8	I-NP	NN	B-protein	34	NMOD	B-protein
O	O	568	569	-	-	B-NP	HYPH	O	34	P	O
O	O	569	575	double	double	I-NP	JJ	O	34	NMOD	O
O	O	575	576	-	-	I-NP	HYPH	O	34	NMOD	O
O	O	576	584	negative	negative	I-NP	JJ	O	34	NMOD	O
O	O	585	586	(	(	O	(	O	33	DEP	O
O	O	586	588	DN	DN	B-ADJP	JJ	O	33	DEP	O
O	O	588	589	)	)	O	)	O	30	AMOD	O
O	O	590	595	stage	stage	B-NP	NN	O	22	PMOD	O
O	O	596	598	of	of	B-PP	IN	O	34	NMOD	O
O	O	599	610	development	development	B-NP	NN	O	35	PMOD	O
O	O	610	611	.	.	O	.	O	19	P	O

O	O	612	619	However	However	B-ADVP	RB	O	5	VMOD	O
O	O	619	620	,	,	O	,	O	5	P	O
O	O	621	624	its	its	B-NP	PRP$	O	4	NMOD	O
O	O	625	633	activity	activity	I-NP	NN	O	5	SUB	O
O	O	634	641	becomes	become	B-VP	VBZ	O	0	ROOT	O
O	O	642	647	lower	low	B-ADJP	JJR	O	5	PRD	O
O	O	648	650	in	in	B-PP	IN	O	6	AMOD	O
O	O	651	654	the	the	B-NP	DT	O	14	NMOD	O
O	O	655	661	double	double	I-NP	JJ	O	14	NMOD	O
O	O	661	662	-	-	I-NP	HYPH	O	14	NMOD	O
O	O	662	670	positive	positive	I-NP	JJ	O	14	NMOD	O
O	O	671	674	and	and	O	CC	O	14	NMOD	O
O	O	675	676	a	a	B-NP	DT	O	14	NMOD	O
O	O	677	685	fraction	fraction	I-NP	NN	O	7	PMOD	O
O	O	686	688	of	of	B-PP	IN	O	14	NMOD	O
O	O	689	692	the	the	B-NP	DT	O	23	NMOD	O
O	O	693	696	CD4	CD4	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	696	697	+	+	B-NP	SYM	O	23	NMOD	O
O	O	698	704	CD8int	CD8int	I-NP	NN	O	23	NMOD	O
O	O	704	705	/	/	B-NP	SYM	O	23	NMOD	O
O	O	705	706	-	-	B-NP	HYPH	O	23	NMOD	O
O	O	707	711	cell	cell	I-NP	NN	O	23	NMOD	O
O	O	712	722	population	population	I-NP	NN	O	15	PMOD	O
O	O	722	723	,	,	O	,	O	5	P	O
O	O	724	734	indicating	indicate	B-VP	VBG	O	5	VMOD	O
O	O	735	739	that	that	B-SBAR	IN	O	25	VMOD	O
O	O	740	742	an	an	B-NP	DT	O	29	NMOD	O
O	O	743	753	additional	additional	I-NP	JJ	O	29	NMOD	O
T22	B-Entity	754	762	enhancer	enhancer	I-NP	NN	B-DNA	45	SUB	B-DNA
O	O	762	763	,	,	O	,	O	29	P	O
O	O	764	771	located	located	B-ADJP	JJ	O	29	NMOD	O
O	O	772	774	in	in	B-PP	IN	O	31	AMOD	O
O	O	775	781	either	either	O	CC	O	39	NMOD	O
O	O	782	785	the	the	B-NP	DT	O	35	NMOD	O
O	O	786	791	first	first	I-NP	JJ	O	39	NMOD	O
O	O	792	794	or	or	O	CC	O	39	NMOD	O
O	O	795	798	the	the	B-NP	DT	O	39	NMOD	O
O	O	799	804	third	third	I-NP	JJ	B-DNA	39	NMOD	B-DNA
T23	B-Entity	805	811	intron	intron	I-NP	NN	I-DNA	32	PMOD	I-DNA
O	O	812	814	of	of	B-PP	IN	O	39	NMOD	O
O	O	815	818	the	the	B-NP	DT	O	43	NMOD	O
T5	B-Protein	819	822	CD4	CD4	I-NP	NN	B-DNA	43	NMOD	B-DNA
O	O	823	827	gene	gene	I-NP	NN	I-DNA	40	PMOD	I-DNA
O	O	827	828	,	,	O	,	O	29	P	O
O	O	829	831	is	be	B-VP	VBZ	O	26	SBAR	O
O	O	832	840	required	require	I-VP	VBN	O	45	VC	O
O	O	841	844	for	for	B-PP	IN	O	46	VMOD	O
T6	B-Protein	845	848	CD4	CD4	B-NP	NN	B-DNA	50	NMOD	B-DNA
O	O	849	853	gene	gene	I-NP	NN	I-DNA	50	NMOD	I-DNA
O	O	854	864	expression	expression	I-NP	NN	O	47	PMOD	O
O	O	865	867	in	in	B-PP	IN	O	50	NMOD	O
O	O	868	872	this	this	B-NP	DT	O	53	NMOD	O
O	O	873	883	population	population	I-NP	NN	O	51	PMOD	O
O	O	883	884	.	.	O	.	O	5	P	O

O	O	885	888	The	The	B-NP	DT	O	2	NMOD	O
O	O	889	894	other	other	I-NP	JJ	O	6	SUB	O
O	O	895	902	studied	study	I-NP	VBN	O	2	NMOD	O
T24	B-Entity	903	913	regulatory	regulatory	I-NP	JJ	B-DNA	5	NMOD	B-DNA
T24	I-Entity	914	921	element	element	I-NP	NN	I-DNA	2	NMOD	I-DNA
O	O	922	924	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	925	928	the	the	B-NP	DT	O	10	NMOD	O
T25	B-Entity	929	936	minimal	minimal	I-NP	JJ	B-DNA	10	NMOD	B-DNA
T7,T25	B-Protein,I-Entity	937	940	CD4	CD4	I-NP	NN	I-DNA	10	NMOD	I-DNA
T25	I-Entity	941	949	silencer	silencer	I-NP	NN	I-DNA	6	PRD	I-DNA
O	O	950	955	which	which	B-NP	WDT	O	10	NMOD	O
O	O	956	964	inhibits	inhibit	B-VP	VBZ	O	11	SBAR	O
T8	B-Protein	965	968	CD4	CD4	B-NP	NN	B-DNA	15	NMOD	B-DNA
O	O	969	973	gene	gene	I-NP	NN	I-DNA	15	NMOD	I-DNA
O	O	974	984	expression	expression	I-NP	NN	O	12	OBJ	O
O	O	985	987	in	in	B-PP	IN	O	15	NMOD	O
O	O	988	998	peripheral	peripheral	B-NP	JJ	B-cell_type	20	NMOD	B-cell_type
T26	B-Entity	999	1002	CD8	CD8	I-NP	NN	I-cell_type	20	NMOD	I-cell_type
O	O	1003	1004	T	T	I-NP	NN	I-cell_type	20	NMOD	I-cell_type
O	O	1005	1016	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	1016	1017	.	.	O	.	O	6	P	O

O	O	1018	1022	This	This	B-NP	DT	O	2	NMOD	O
O	O	1023	1031	silencer	silencer	I-NP	NN	B-DNA	3	SUB	B-DNA
O	O	1032	1034	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1035	1043	inactive	inactive	B-ADJP	JJ	O	3	PRD	O
O	O	1044	1046	in	in	B-PP	IN	O	4	AMOD	O
O	O	1047	1050	the	the	B-NP	DT	O	10	NMOD	O
O	O	1051	1055	most	most	I-NP	RBS	O	10	NMOD	O
O	O	1056	1064	immature	immature	I-NP	JJ	B-cell_type	10	NMOD	B-cell_type
O	O	1065	1067	DN	DN	I-NP	JJ	I-cell_type	10	NMOD	I-cell_type
O	O	1068	1078	thymocytes	thymocyte	I-NP	NNS	I-cell_type	5	PMOD	I-cell_type
O	O	1078	1079	,	,	O	,	O	10	P	O
O	O	1080	1085	which	which	B-NP	WDT	O	10	NMOD	O
O	O	1086	1094	probably	probably	B-ADVP	RB	O	14	VMOD	O
O	O	1095	1098	use	use	B-VP	VBP	O	12	SBAR	O
O	O	1099	1100	a	a	B-NP	DT	O	18	NMOD	O
O	O	1101	1109	distinct	distinct	I-NP	JJ	O	18	NMOD	O
T27	B-Entity	1110	1118	silencer	silencer	I-NP	NN	O	18	NMOD	O
T27	I-Entity	1119	1128	mechanism	mechanism	I-NP	NN	O	14	OBJ	O
O	O	1129	1131	to	to	B-VP	TO	O	14	VMOD	O
O	O	1132	1136	down	down	I-VP	RB	O	19	PMOD	O
O	O	1136	1137	-	-	I-VP	HYPH	O	14	VMOD	O
O	O	1137	1145	regulate	regulate	I-VP	VB	O	21	VMOD	O
T9	B-Protein	1146	1149	CD4	CD4	B-NP	NN	B-DNA	25	NMOD	B-DNA
O	O	1150	1154	gene	gene	I-NP	NN	I-DNA	25	NMOD	I-DNA
O	O	1155	1165	expression	expression	I-NP	NN	O	22	OBJ	O
O	O	1165	1166	.	.	O	.	O	3	P	O

O	O	1167	1179	Unexpectedly	Unexpectedly	B-ADVP	RB	O	6	VMOD	O
O	O	1179	1180	,	,	O	,	O	6	P	O
O	O	1181	1184	the	the	B-NP	DT	O	5	NMOD	O
T10,T28	B-Protein,B-Entity	1185	1188	CD4	CD4	I-NP	NN	B-DNA	5	NMOD	B-DNA
T28	I-Entity	1189	1197	silencer	silencer	I-NP	NN	I-DNA	6	SUB	I-DNA
O	O	1198	1200	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1201	1205	also	also	B-ADVP	RB	O	6	VMOD	O
O	O	1206	1212	active	active	B-ADJP	JJ	O	6	PRD	O
O	O	1213	1215	in	in	B-PP	IN	O	8	AMOD	O
T11	B-Protein	1216	1219	CD4	CD4	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	1219	1220	+	+	B-NP	SYM	O	12	NMOD	O
T29	B-Entity	1221	1227	CD8int	CD8int	I-NP	NN	O	9	PMOD	O
O	O	1227	1228	/	/	O	SYM	O	14	P	O
O	O	1228	1229	-	-	O	HYPH	O	12	NMOD	O
O	O	1230	1235	cells	cell	B-NP	NNS	O	14	OBJ	O
O	O	1236	1238	of	of	B-PP	IN	O	15	NMOD	O
O	O	1239	1242	the	the	B-NP	DT	O	18	NMOD	O
O	O	1243	1249	thymus	thymus	I-NP	NN	O	16	PMOD	O
O	O	1249	1250	,	,	O	,	O	6	P	O
O	O	1251	1259	implying	imply	B-VP	VBG	O	6	VMOD	O
O	O	1260	1264	that	that	B-SBAR	IN	O	20	VMOD	O
O	O	1265	1267	an	an	B-NP	DT	O	25	NMOD	O
T30	B-Entity	1268	1272	anti	anti	I-NP	AFX	O	25	NMOD	O
T30	I-Entity	1272	1273	-	-	I-NP	HYPH	B-DNA	25	NMOD	B-DNA
T30	I-Entity	1273	1281	silencer	silencer	I-NP	NN	I-DNA	26	SUB	I-DNA
O	O	1282	1285	may	may	B-VP	MD	O	21	SBAR	O
O	O	1286	1288	be	be	I-VP	VB	O	26	VC	O
O	O	1289	1297	required	require	I-VP	VBN	O	27	VC	O
O	O	1298	1300	to	to	I-VP	TO	O	30	VMOD	O
O	O	1301	1307	resume	resume	I-VP	VB	O	26	VMOD	O
T12	B-Protein	1308	1311	CD4	CD4	B-NP	NN	B-protein	32	NMOD	B-protein
O	O	1312	1322	expression	expression	I-NP	NN	O	30	OBJ	O
O	O	1323	1325	in	in	B-PP	IN	O	32	NMOD	O
O	O	1326	1330	this	this	B-NP	DT	O	36	NMOD	O
O	O	1331	1335	cell	cell	I-NP	NN	O	36	NMOD	O
O	O	1336	1346	population	population	I-NP	NN	O	33	PMOD	O
O	O	1346	1347	.	.	O	.	O	6	P	O

O	O	1348	1358	Altogether	Altogether	B-ADVP	RB	O	6	VMOD	O
O	O	1358	1359	,	,	O	,	O	6	P	O
O	O	1360	1363	the	the	B-NP	DT	O	5	NMOD	O
T13	B-Protein	1364	1367	CD4	CD4	I-NP	NN	B-DNA	5	NMOD	B-DNA
O	O	1368	1372	gene	gene	I-NP	NN	I-DNA	6	SUB	I-DNA
O	O	1373	1375	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1376	1385	regulated	regulate	I-VP	VBN	O	6	VC	O
O	O	1386	1388	by	by	B-PP	IN	O	7	VMOD	O
O	O	1389	1396	several	several	B-NP	JJ	O	8	PMOD	O
O	O	1397	1405	positive	positive	I-NP	JJ	O	9	NMOD	O
O	O	1406	1409	and	and	I-NP	CC	O	9	NMOD	O
O	O	1410	1418	negative	negative	I-NP	JJ	O	9	NMOD	O
O	O	1419	1429	regulatory	regulatory	I-NP	JJ	O	14	NMOD	O
O	O	1430	1440	mechanisms	mechanism	I-NP	NNS	O	9	NMOD	O
O	O	1441	1446	which	which	B-NP	WDT	O	9	NMOD	O
O	O	1447	1451	come	come	B-VP	VBP	O	15	SBAR	O
O	O	1452	1456	into	into	B-PP	IN	O	16	VMOD	O
O	O	1457	1461	play	play	B-NP	NN	O	17	PMOD	O
O	O	1462	1464	in	in	B-PP	IN	O	16	VMOD	O
O	O	1465	1466	a	a	B-NP	DT	O	23	NMOD	O
O	O	1467	1482	developmentally	developmentally	I-NP	RB	O	22	AMOD	O
O	O	1483	1494	coordinated	coordinate	I-NP	VBN	O	23	NMOD	O
O	O	1495	1501	manner	manner	I-NP	NN	O	19	PMOD	O
O	O	1501	1502	.	.	O	.	O	6	P	O
